December 2024 - Page 6 of 13

MondayDec 16, 2024 1:34 pm

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Eyes Clear Path Forward for Buntanetap

Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, such as Alzheimer’s (“AD”) and Parkinson’s (“PD”). The company concluded the third quarter with the completion of significant milestones and a clear path forward for its lead candidate, buntanetap. “Buntanetap is an innovative drug designed to target neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein and TDP43,” reads a recent article. “This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying, positioning buntanetap as a potential breakthrough in treating neurodegenerative diseases.”…

MondayDec 16, 2024 11:05 am

QualityStocksNewsBreaks – CannExpo 2025 to Showcase Innovative Products, Trends in Celebration of All Things Cannabis

CannExpo 2025, Toronto's Cannabis Lifestyle Show, is set to blaze into the Queen Elizabeth Building at Exhibition Place on March 21-22, 2025. The event will bring together enthusiasts, curious newcomers and professionals from the cannabis industry. An eclectic mix of exhibitors will be featured, from cutting-edge growers and innovative product developers to trendsetting accessory makers and wellness experts. The one-stop-shop for discovering the latest and greatest in the world of cannabis will be buzzing with engaging panels and discussions on hot topics. To view the full press release, visit https://ibn.fm/rv12p About CannExpo 2025 CannExpo 2025 is more than just an…

MondayDec 16, 2024 9:30 am

US Defense Department Unveils Initiatives to Expedite Adoption of AI Technologies

The Chief Digital and AI office at the Pentagon has launched a rapid fielding effort to pave the way for different initiatives geared at expediting the DoD’s adoption of AI capabilities. Different units within the Pentagon will work together on an initial four AI pilot projects looking into how generative AI can be integrated into DoD enterprise management and warfighting use cases. These four pilot projects form part of the Pentagon’s wider plan to leverage emerging technologies, so that major enablers in the Department of Defense and those who fight wars can benefit from the advantages that these technologies are…

MondayDec 16, 2024 9:10 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device

HeartBeam (NASDAQ: BEAT) has received FDA 510(k) clearance for its groundbreaking HeartBeam system, a credit card-sized, cable-free ECG device designed for comprehensive arrhythmia assessment. The system enables patients to record high-fidelity heart signals from three directions during symptoms, with data transmitted to physicians for timely review and action. This milestone marks the first FDA-cleared device of its kind and lays the foundation for future advancements, including synthesized 12-lead ECGs, AI-driven arrhythmia detection, and heart attack risk assessment. HeartBeam aims to transform cardiac care by delivering actionable insights and predictive diagnostics for patients and physicians globally. To view the full press…

MondayDec 16, 2024 8:45 am

Nightfood Holdings Inc. (NGTF) Subsidiary Recent Partnership Illustrates Transformative Power of AI in Hospitality Space

In the hospitality industry, AI has emerged as a game-changer, addressing challenges such as staffing shortages, operational efficiency and customer satisfaction A standout example of AI’s impact on hospitality is the recent partnership between Future Hospitality Ventures and Bear Robotics The groundbreaking partnership is rooted in the shared vision of making hospitality operations more efficient, scalable and guest friendly Artificial intelligence (“AI”) is redefining industries worldwide, marking its territory as an essential driver of innovation, efficiency and enhanced customer experiences. Businesses across sectors have already leveraged AI in an array of ways. As technology continues to evolve, their applications are expanding from…

MondayDec 16, 2024 8:00 am

QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Advances Exploration at Storm and Epworth Projects in Nunavut

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) provided updates on its 2024 exploration activities at the Storm Copper and Epworth Projects in Nunavut. At Storm, 22,475 meters of drilling confirmed consistent copper grades and identified new targets, with a maiden resource and development study expected in early 2025. At Epworth, Aston Bay expanded its claims by 11,900 hectares, conducted extensive geophysical surveys, and plans to release a comprehensive analysis of the results in January. Additional drilling at Storm refined the geological model, with new discoveries at the Squall Prospect highlighting promising mineralization, including assays of 2.4% copper and 5 g/t silver.…

MondayDec 16, 2024 8:00 am

Blockchain Africa Conference 2024 Witnesses Phenomenal Response

The 10th edition of the Blockchain Africa Conference was successfully hosted by Bitcoin Events at the CSIR International Convention Centre, on November 20, 2024, in Tshwane, South Africa. The in-person event witnessed around 500 attendees, which included an impressive line-up of dignitaries along with aspiring and established participants from the blockchain and cryptocurrency spectrum in Africa and beyond. The event venue, the CSIR International Convention Centre in Pretoria (Tshwane), is close to all major amenities, and is well-connected by all major routes in Gauteng. With over 10 years of experience, the Blockchain Africa Conference offers a robust platform for learning, networking…

FridayDec 13, 2024 1:00 pm

Annovis Bio Inc. (NYSE: ANVS) Showcases 2024 Achievements and Strategic Vision in Year-End Investor Webcast

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company pioneering transformative therapies for neurodegenerative diseases, recently hosted its Year-End Investor Webcast, providing stakeholders with a comprehensive overview of the company's 2024 milestones and strategic initiatives for 2025. The full webcast is available here: https://youtu.be/NA3kCUZZIpI. During the webcast, Dr. Maria Maccecchini, Founder, President, and CEO of Annovis Bio, detailed significant progress in the company's pivotal Phase 3 studies for Buntanetap, its lead drug candidate targeting neurodegenerative conditions such as Alzheimer's and Parkinson's diseases. These studies aim to demonstrate both symptomatic relief and disease-modifying effects, aligning with Annovis Bio's mission to address…

FridayDec 13, 2024 12:15 pm

Clene Inc. (NASDAQ: CLNN) Receives FDA Guidance on Accelerated Approval Pathway for CNM-Au8(R) for ALS

The FDA asked for additional Neurofilament Light (“NfL”) data from the company’s three Expanded Access Protocols to support earlier clinical trial findings. The company has already begun collecting and analyzing this data, with plans to complete the process in Q2 2025 and then submit a New Drug Application (“NDA”) for CNM-Au8 by mid-2025. A follow-up meeting with the FDA will be held early next year to discuss and finalize the statistical analysis plan for the EAP NfL biomarker analyses. The company is meanwhile preparing a confirmatory Phase 3 trial (“RESTORE-ALS”) to evaluate the survival benefit of CNM-Au8 with initial participant…

FridayDec 13, 2024 11:45 am

Brera Holdings PLC (NASDAQ: BREA) SEC Filing Reveals JPMorgan Chase’s Ownership of Ordinary Shares

JPMorgan Chase shows significant interest in Brera Holdings, according to a recent SEC 6K filing, providing insight into institutional confidence and potential strategic alignments. The Chase investment signals confidence in Brera from a leading financial institution, enhancing its credibility among investors and partners. Brera’s recent investment in Juve Stabia, an Italian Serie B soccer club, aligns with the company’s multi-club ownership strategy. Earlier this week JPMorgan Chase & Co. disclosed its 5.3% stake in Brera Holdings PLC via an SEC 6K filing through its investment management activities. Made in accordance with the Irish Companies Act, this announcement highlights Chase's aggregate…

Site Search

Company Search

Month: December 2024